nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A4—Temozolomide—malignant glioma	0.104	1	CbGbCtD
Oxycodone—Disease progression—Carmustine—malignant glioma	0.028	0.0429	CcSEcCtD
Oxycodone—Ethylmorphine—POR—malignant glioma	0.0162	0.573	CrCbGaD
Oxycodone—Intracranial pressure increased—Carmustine—malignant glioma	0.0146	0.0224	CcSEcCtD
Oxycodone—Personality disorder—Carmustine—malignant glioma	0.0141	0.0217	CcSEcCtD
Oxycodone—Azotaemia—Carmustine—malignant glioma	0.0115	0.0176	CcSEcCtD
Oxycodone—Deep vein thrombosis—Temozolomide—malignant glioma	0.00972	0.0149	CcSEcCtD
Oxycodone—Hypokinesia—Carmustine—malignant glioma	0.00906	0.0139	CcSEcCtD
Oxycodone—Lung disorder—Temozolomide—malignant glioma	0.00835	0.0128	CcSEcCtD
Oxycodone—Stupor—Carmustine—malignant glioma	0.0082	0.0125	CcSEcCtD
Oxycodone—Cholestasis—Temozolomide—malignant glioma	0.00779	0.0119	CcSEcCtD
Oxycodone—Hyperaesthesia—Temozolomide—malignant glioma	0.00753	0.0115	CcSEcCtD
Oxycodone—Endocrine disorder—Temozolomide—malignant glioma	0.00713	0.0109	CcSEcCtD
Oxycodone—Speech disorder—Carmustine—malignant glioma	0.00711	0.0109	CcSEcCtD
Oxycodone—Accidental injury—Carmustine—malignant glioma	0.00692	0.0106	CcSEcCtD
Oxycodone—Speech disorder—Temozolomide—malignant glioma	0.00688	0.0105	CcSEcCtD
Oxycodone—Amenorrhoea—Temozolomide—malignant glioma	0.00673	0.0103	CcSEcCtD
Oxycodone—Thinking abnormal—Carmustine—malignant glioma	0.00668	0.0102	CcSEcCtD
Oxycodone—Drug interaction—Carmustine—malignant glioma	0.0066	0.0101	CcSEcCtD
Oxycodone—Herpes simplex—Temozolomide—malignant glioma	0.00642	0.00982	CcSEcCtD
Oxycodone—Gait disturbance—Carmustine—malignant glioma	0.00627	0.0096	CcSEcCtD
Oxycodone—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00625	0.00957	CcSEcCtD
Oxycodone—Neck pain—Carmustine—malignant glioma	0.00619	0.00948	CcSEcCtD
Oxycodone—Gait disturbance—Temozolomide—malignant glioma	0.00606	0.00927	CcSEcCtD
Oxycodone—Respiratory failure—Temozolomide—malignant glioma	0.00602	0.00922	CcSEcCtD
Oxycodone—Depressed level of consciousness—Carmustine—malignant glioma	0.00591	0.00904	CcSEcCtD
Oxycodone—Ethylmorphine—CYP2B6—malignant glioma	0.00578	0.205	CrCbGaD
Oxycodone—Depressed level of consciousness—Temozolomide—malignant glioma	0.00571	0.00874	CcSEcCtD
Oxycodone—Coma—Carmustine—malignant glioma	0.00559	0.00856	CcSEcCtD
Oxycodone—Abnormal vision—Carmustine—malignant glioma	0.00534	0.00817	CcSEcCtD
Oxycodone—Sepsis—Carmustine—malignant glioma	0.00531	0.00813	CcSEcCtD
Oxycodone—Mental disability—Carmustine—malignant glioma	0.00531	0.00813	CcSEcCtD
Oxycodone—Abnormal vision—Temozolomide—malignant glioma	0.00516	0.00789	CcSEcCtD
Oxycodone—Mental disability—Temozolomide—malignant glioma	0.00513	0.00785	CcSEcCtD
Oxycodone—Thrombophlebitis—Carmustine—malignant glioma	0.00513	0.00785	CcSEcCtD
Oxycodone—Swelling—Carmustine—malignant glioma	0.00503	0.00771	CcSEcCtD
Oxycodone—Thrombophlebitis—Temozolomide—malignant glioma	0.00496	0.00759	CcSEcCtD
Oxycodone—Injury—Carmustine—malignant glioma	0.00483	0.0074	CcSEcCtD
Oxycodone—Amnesia—Carmustine—malignant glioma	0.00473	0.00724	CcSEcCtD
Oxycodone—Amnesia—Temozolomide—malignant glioma	0.00457	0.00699	CcSEcCtD
Oxycodone—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00455	0.00696	CcSEcCtD
Oxycodone—Thirst—Temozolomide—malignant glioma	0.00451	0.0069	CcSEcCtD
Oxycodone—Hyponatraemia—Carmustine—malignant glioma	0.00446	0.00683	CcSEcCtD
Oxycodone—Face oedema—Carmustine—malignant glioma	0.00429	0.00656	CcSEcCtD
Oxycodone—Affect lability—Temozolomide—malignant glioma	0.00423	0.00647	CcSEcCtD
Oxycodone—Face oedema—Temozolomide—malignant glioma	0.00414	0.00634	CcSEcCtD
Oxycodone—Mood swings—Temozolomide—malignant glioma	0.00407	0.00622	CcSEcCtD
Oxycodone—Dehydration—Temozolomide—malignant glioma	0.00399	0.00611	CcSEcCtD
Oxycodone—Dry skin—Temozolomide—malignant glioma	0.00393	0.00602	CcSEcCtD
Oxycodone—Breast disorder—Temozolomide—malignant glioma	0.00388	0.00594	CcSEcCtD
Oxycodone—Dysphagia—Carmustine—malignant glioma	0.00384	0.00588	CcSEcCtD
Oxycodone—Abdominal distension—Temozolomide—malignant glioma	0.00373	0.00572	CcSEcCtD
Oxycodone—Dysphagia—Temozolomide—malignant glioma	0.00371	0.00568	CcSEcCtD
Oxycodone—Bronchitis—Temozolomide—malignant glioma	0.00357	0.00546	CcSEcCtD
Oxycodone—Dysuria—Temozolomide—malignant glioma	0.00347	0.00531	CcSEcCtD
Oxycodone—Hyperglycaemia—Carmustine—malignant glioma	0.00346	0.0053	CcSEcCtD
Oxycodone—Pneumonia—Carmustine—malignant glioma	0.00344	0.00527	CcSEcCtD
Oxycodone—Erectile dysfunction—Temozolomide—malignant glioma	0.00342	0.00523	CcSEcCtD
Oxycodone—Galantamine—BCHE—malignant glioma	0.00341	0.121	CrCbGaD
Oxycodone—Photosensitivity reaction—Temozolomide—malignant glioma	0.00339	0.00518	CcSEcCtD
Oxycodone—Weight decreased—Temozolomide—malignant glioma	0.00336	0.00514	CcSEcCtD
Oxycodone—Hyperglycaemia—Temozolomide—malignant glioma	0.00335	0.00512	CcSEcCtD
Oxycodone—Stomatitis—Carmustine—malignant glioma	0.00334	0.00511	CcSEcCtD
Oxycodone—Urinary tract infection—Carmustine—malignant glioma	0.00333	0.00509	CcSEcCtD
Oxycodone—Pneumonia—Temozolomide—malignant glioma	0.00333	0.00509	CcSEcCtD
Oxycodone—Infestation—Temozolomide—malignant glioma	0.00331	0.00506	CcSEcCtD
Oxycodone—Infestation NOS—Temozolomide—malignant glioma	0.00331	0.00506	CcSEcCtD
Oxycodone—Stomatitis—Temozolomide—malignant glioma	0.00322	0.00494	CcSEcCtD
Oxycodone—Urinary tract infection—Temozolomide—malignant glioma	0.00322	0.00492	CcSEcCtD
Oxycodone—Hepatobiliary disease—Temozolomide—malignant glioma	0.00313	0.00479	CcSEcCtD
Oxycodone—Sinusitis—Temozolomide—malignant glioma	0.0031	0.00475	CcSEcCtD
Oxycodone—Haemoglobin—Carmustine—malignant glioma	0.00309	0.00473	CcSEcCtD
Oxycodone—Haemorrhage—Carmustine—malignant glioma	0.00307	0.0047	CcSEcCtD
Oxycodone—Hallucination—Carmustine—malignant glioma	0.00306	0.00468	CcSEcCtD
Oxycodone—Hypoaesthesia—Carmustine—malignant glioma	0.00306	0.00468	CcSEcCtD
Oxycodone—Oedema peripheral—Carmustine—malignant glioma	0.00303	0.00463	CcSEcCtD
Oxycodone—Connective tissue disorder—Carmustine—malignant glioma	0.00302	0.00462	CcSEcCtD
Oxycodone—Haemoglobin—Temozolomide—malignant glioma	0.00298	0.00457	CcSEcCtD
Oxycodone—Haemorrhage—Temozolomide—malignant glioma	0.00297	0.00455	CcSEcCtD
Oxycodone—Hepatitis—Temozolomide—malignant glioma	0.00297	0.00455	CcSEcCtD
Oxycodone—Visual impairment—Carmustine—malignant glioma	0.00296	0.00453	CcSEcCtD
Oxycodone—Hypoaesthesia—Temozolomide—malignant glioma	0.00295	0.00452	CcSEcCtD
Oxycodone—Hallucination—Temozolomide—malignant glioma	0.00295	0.00452	CcSEcCtD
Oxycodone—Pharyngitis—Temozolomide—malignant glioma	0.00295	0.00451	CcSEcCtD
Oxycodone—Urinary tract disorder—Temozolomide—malignant glioma	0.00293	0.00449	CcSEcCtD
Oxycodone—Oedema peripheral—Temozolomide—malignant glioma	0.00293	0.00448	CcSEcCtD
Oxycodone—Connective tissue disorder—Temozolomide—malignant glioma	0.00292	0.00447	CcSEcCtD
Oxycodone—Urethral disorder—Temozolomide—malignant glioma	0.00291	0.00446	CcSEcCtD
Oxycodone—Hydromorphone—PTGS1—malignant glioma	0.00288	0.102	CrCbGaD
Oxycodone—Eye disorder—Carmustine—malignant glioma	0.00287	0.0044	CcSEcCtD
Oxycodone—Visual impairment—Temozolomide—malignant glioma	0.00286	0.00438	CcSEcCtD
Oxycodone—Flushing—Carmustine—malignant glioma	0.00285	0.00437	CcSEcCtD
Oxycodone—Eye disorder—Temozolomide—malignant glioma	0.00278	0.00425	CcSEcCtD
Oxycodone—Tinnitus—Temozolomide—malignant glioma	0.00277	0.00424	CcSEcCtD
Oxycodone—Flushing—Temozolomide—malignant glioma	0.00276	0.00422	CcSEcCtD
Oxycodone—Cardiac disorder—Temozolomide—malignant glioma	0.00276	0.00422	CcSEcCtD
Oxycodone—Angiopathy—Temozolomide—malignant glioma	0.00269	0.00412	CcSEcCtD
Oxycodone—Mental disorder—Carmustine—malignant glioma	0.00269	0.00412	CcSEcCtD
Oxycodone—Immune system disorder—Temozolomide—malignant glioma	0.00268	0.00411	CcSEcCtD
Oxycodone—Mediastinal disorder—Temozolomide—malignant glioma	0.00268	0.0041	CcSEcCtD
Oxycodone—Malnutrition—Carmustine—malignant glioma	0.00267	0.00409	CcSEcCtD
Oxycodone—Chills—Temozolomide—malignant glioma	0.00266	0.00408	CcSEcCtD
Oxycodone—Mental disorder—Temozolomide—malignant glioma	0.0026	0.00398	CcSEcCtD
Oxycodone—Back pain—Carmustine—malignant glioma	0.00259	0.00396	CcSEcCtD
Oxycodone—Malnutrition—Temozolomide—malignant glioma	0.00259	0.00396	CcSEcCtD
Oxycodone—Dysgeusia—Temozolomide—malignant glioma	0.00253	0.00387	CcSEcCtD
Oxycodone—Tremor—Carmustine—malignant glioma	0.00251	0.00384	CcSEcCtD
Oxycodone—Back pain—Temozolomide—malignant glioma	0.0025	0.00383	CcSEcCtD
Oxycodone—Anaemia—Carmustine—malignant glioma	0.00247	0.00378	CcSEcCtD
Oxycodone—Agitation—Carmustine—malignant glioma	0.00246	0.00376	CcSEcCtD
Oxycodone—Tremor—Temozolomide—malignant glioma	0.00242	0.00371	CcSEcCtD
Oxycodone—Ill-defined disorder—Temozolomide—malignant glioma	0.0024	0.00367	CcSEcCtD
Oxycodone—Leukopenia—Carmustine—malignant glioma	0.00239	0.00367	CcSEcCtD
Oxycodone—Anaemia—Temozolomide—malignant glioma	0.00239	0.00366	CcSEcCtD
Oxycodone—Agitation—Temozolomide—malignant glioma	0.00238	0.00364	CcSEcCtD
Oxycodone—Angioedema—Temozolomide—malignant glioma	0.00236	0.00362	CcSEcCtD
Oxycodone—Malaise—Temozolomide—malignant glioma	0.00233	0.00357	CcSEcCtD
Oxycodone—Vertigo—Temozolomide—malignant glioma	0.00232	0.00355	CcSEcCtD
Oxycodone—Convulsion—Carmustine—malignant glioma	0.00232	0.00355	CcSEcCtD
Oxycodone—Leukopenia—Temozolomide—malignant glioma	0.00231	0.00354	CcSEcCtD
Oxycodone—Palpitations—Temozolomide—malignant glioma	0.00228	0.0035	CcSEcCtD
Oxycodone—Chest pain—Carmustine—malignant glioma	0.00228	0.00349	CcSEcCtD
Oxycodone—Myalgia—Carmustine—malignant glioma	0.00228	0.00349	CcSEcCtD
Oxycodone—Anxiety—Carmustine—malignant glioma	0.00227	0.00347	CcSEcCtD
Oxycodone—Cough—Temozolomide—malignant glioma	0.00226	0.00345	CcSEcCtD
Oxycodone—Convulsion—Temozolomide—malignant glioma	0.00224	0.00343	CcSEcCtD
Oxycodone—Confusional state—Carmustine—malignant glioma	0.0022	0.00337	CcSEcCtD
Oxycodone—Arthralgia—Temozolomide—malignant glioma	0.0022	0.00337	CcSEcCtD
Oxycodone—Myalgia—Temozolomide—malignant glioma	0.0022	0.00337	CcSEcCtD
Oxycodone—Anxiety—Temozolomide—malignant glioma	0.00219	0.00336	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00219	0.00335	CcSEcCtD
Oxycodone—Oedema—Carmustine—malignant glioma	0.00218	0.00334	CcSEcCtD
Oxycodone—Discomfort—Temozolomide—malignant glioma	0.00217	0.00333	CcSEcCtD
Oxycodone—Infection—Carmustine—malignant glioma	0.00217	0.00332	CcSEcCtD
Oxycodone—Dry mouth—Temozolomide—malignant glioma	0.00215	0.00329	CcSEcCtD
Oxycodone—Tachycardia—Carmustine—malignant glioma	0.00213	0.00326	CcSEcCtD
Oxycodone—Confusional state—Temozolomide—malignant glioma	0.00213	0.00326	CcSEcCtD
Oxycodone—Oedema—Temozolomide—malignant glioma	0.00211	0.00323	CcSEcCtD
Oxycodone—Anaphylactic shock—Temozolomide—malignant glioma	0.00211	0.00323	CcSEcCtD
Oxycodone—Infection—Temozolomide—malignant glioma	0.0021	0.00321	CcSEcCtD
Oxycodone—Anorexia—Carmustine—malignant glioma	0.00208	0.00319	CcSEcCtD
Oxycodone—Nervous system disorder—Temozolomide—malignant glioma	0.00207	0.00317	CcSEcCtD
Oxycodone—Skin disorder—Temozolomide—malignant glioma	0.00205	0.00314	CcSEcCtD
Oxycodone—Hypotension—Carmustine—malignant glioma	0.00204	0.00312	CcSEcCtD
Oxycodone—Hyperhidrosis—Temozolomide—malignant glioma	0.00204	0.00312	CcSEcCtD
Oxycodone—Anorexia—Temozolomide—malignant glioma	0.00201	0.00308	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00199	0.00304	CcSEcCtD
Oxycodone—Insomnia—Carmustine—malignant glioma	0.00197	0.00302	CcSEcCtD
Oxycodone—Paraesthesia—Carmustine—malignant glioma	0.00196	0.003	CcSEcCtD
Oxycodone—Dyspnoea—Carmustine—malignant glioma	0.00195	0.00298	CcSEcCtD
Oxycodone—Somnolence—Carmustine—malignant glioma	0.00194	0.00297	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00192	0.00294	CcSEcCtD
Oxycodone—Insomnia—Temozolomide—malignant glioma	0.00191	0.00292	CcSEcCtD
Oxycodone—Decreased appetite—Carmustine—malignant glioma	0.0019	0.0029	CcSEcCtD
Oxycodone—Paraesthesia—Temozolomide—malignant glioma	0.00189	0.0029	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Carmustine—malignant glioma	0.00188	0.00288	CcSEcCtD
Oxycodone—Dyspnoea—Temozolomide—malignant glioma	0.00188	0.00288	CcSEcCtD
Oxycodone—Somnolence—Temozolomide—malignant glioma	0.00188	0.00287	CcSEcCtD
Oxycodone—Pain—Carmustine—malignant glioma	0.00187	0.00286	CcSEcCtD
Oxycodone—Constipation—Carmustine—malignant glioma	0.00187	0.00286	CcSEcCtD
Oxycodone—Dyspepsia—Temozolomide—malignant glioma	0.00186	0.00284	CcSEcCtD
Oxycodone—Decreased appetite—Temozolomide—malignant glioma	0.00183	0.00281	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00182	0.00279	CcSEcCtD
Oxycodone—Fatigue—Temozolomide—malignant glioma	0.00182	0.00278	CcSEcCtD
Oxycodone—Constipation—Temozolomide—malignant glioma	0.0018	0.00276	CcSEcCtD
Oxycodone—Pain—Temozolomide—malignant glioma	0.0018	0.00276	CcSEcCtD
Oxycodone—Feeling abnormal—Carmustine—malignant glioma	0.0018	0.00275	CcSEcCtD
Oxycodone—Gastrointestinal pain—Carmustine—malignant glioma	0.00179	0.00273	CcSEcCtD
Oxycodone—Feeling abnormal—Temozolomide—malignant glioma	0.00174	0.00266	CcSEcCtD
Oxycodone—Abdominal pain—Carmustine—malignant glioma	0.00173	0.00264	CcSEcCtD
Oxycodone—Body temperature increased—Carmustine—malignant glioma	0.00173	0.00264	CcSEcCtD
Oxycodone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00173	0.00264	CcSEcCtD
Oxycodone—Urticaria—Temozolomide—malignant glioma	0.00168	0.00257	CcSEcCtD
Oxycodone—Abdominal pain—Temozolomide—malignant glioma	0.00167	0.00255	CcSEcCtD
Oxycodone—Body temperature increased—Temozolomide—malignant glioma	0.00167	0.00255	CcSEcCtD
Oxycodone—Hypersensitivity—Carmustine—malignant glioma	0.00161	0.00246	CcSEcCtD
Oxycodone—Asthenia—Carmustine—malignant glioma	0.00157	0.0024	CcSEcCtD
Oxycodone—Hypersensitivity—Temozolomide—malignant glioma	0.00155	0.00238	CcSEcCtD
Oxycodone—Asthenia—Temozolomide—malignant glioma	0.00151	0.00232	CcSEcCtD
Oxycodone—Diarrhoea—Carmustine—malignant glioma	0.00149	0.00229	CcSEcCtD
Oxycodone—Pruritus—Temozolomide—malignant glioma	0.00149	0.00228	CcSEcCtD
Oxycodone—Dizziness—Carmustine—malignant glioma	0.00144	0.00221	CcSEcCtD
Oxycodone—Diarrhoea—Temozolomide—malignant glioma	0.00144	0.00221	CcSEcCtD
Oxycodone—Dizziness—Temozolomide—malignant glioma	0.0014	0.00214	CcSEcCtD
Oxycodone—Vomiting—Carmustine—malignant glioma	0.00139	0.00212	CcSEcCtD
Oxycodone—Rash—Carmustine—malignant glioma	0.00138	0.00211	CcSEcCtD
Oxycodone—Dermatitis—Carmustine—malignant glioma	0.00138	0.0021	CcSEcCtD
Oxycodone—Headache—Carmustine—malignant glioma	0.00137	0.00209	CcSEcCtD
Oxycodone—Vomiting—Temozolomide—malignant glioma	0.00134	0.00205	CcSEcCtD
Oxycodone—Rash—Temozolomide—malignant glioma	0.00133	0.00204	CcSEcCtD
Oxycodone—Dermatitis—Temozolomide—malignant glioma	0.00133	0.00203	CcSEcCtD
Oxycodone—Headache—Temozolomide—malignant glioma	0.00132	0.00202	CcSEcCtD
Oxycodone—Nausea—Carmustine—malignant glioma	0.0013	0.00198	CcSEcCtD
Oxycodone—Nausea—Temozolomide—malignant glioma	0.00125	0.00192	CcSEcCtD
Oxycodone—OPRD1—Signaling Pathways—HES1—malignant glioma	9.13e-05	0.000427	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NTRK1—malignant glioma	9.11e-05	0.000426	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NCOR1—malignant glioma	9.08e-05	0.000424	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FBXW7—malignant glioma	9.06e-05	0.000423	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—RAF1—malignant glioma	8.96e-05	0.000418	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BDKRB2—malignant glioma	8.88e-05	0.000415	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—IL2—malignant glioma	8.85e-05	0.000413	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—F2—malignant glioma	8.84e-05	0.000413	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CD—malignant glioma	8.8e-05	0.000411	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CB—malignant glioma	8.75e-05	0.000409	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PDGFRA—malignant glioma	8.7e-05	0.000406	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—COX8A—malignant glioma	8.6e-05	0.000402	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT2—malignant glioma	8.52e-05	0.000398	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—IDH2—malignant glioma	8.47e-05	0.000396	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP3—malignant glioma	8.47e-05	0.000396	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CG—malignant glioma	8.46e-05	0.000395	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CB—malignant glioma	8.45e-05	0.000395	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SPP1—malignant glioma	8.44e-05	0.000394	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCL8—malignant glioma	8.41e-05	0.000393	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN2B—malignant glioma	8.4e-05	0.000392	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PTPN11—malignant glioma	8.31e-05	0.000388	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH2—malignant glioma	8.26e-05	0.000386	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CD—malignant glioma	8.19e-05	0.000383	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTK2—malignant glioma	8.15e-05	0.000381	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCL8—malignant glioma	8.12e-05	0.000379	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KNG1—malignant glioma	8.08e-05	0.000377	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL2—malignant glioma	8.03e-05	0.000375	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HES1—malignant glioma	8.01e-05	0.000374	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TERT—malignant glioma	8e-05	0.000374	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2B6—malignant glioma	7.97e-05	0.000372	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NCOR1—malignant glioma	7.96e-05	0.000372	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—RAF1—malignant glioma	7.86e-05	0.000367	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTT1—malignant glioma	7.86e-05	0.000367	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PDGFB—malignant glioma	7.81e-05	0.000365	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGFR1—malignant glioma	7.77e-05	0.000363	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL2—malignant glioma	7.76e-05	0.000362	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT2—malignant glioma	7.74e-05	0.000362	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NTRK1—malignant glioma	7.7e-05	0.00036	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CB—malignant glioma	7.67e-05	0.000358	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HIF1A—malignant glioma	7.65e-05	0.000358	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PDGFRA—malignant glioma	7.63e-05	0.000356	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTP1—malignant glioma	7.53e-05	0.000352	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CD—malignant glioma	7.44e-05	0.000347	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SPP1—malignant glioma	7.4e-05	0.000346	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CAV1—malignant glioma	7.4e-05	0.000346	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL8—malignant glioma	7.37e-05	0.000344	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS1—malignant glioma	7.36e-05	0.000344	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CAT—malignant glioma	7.33e-05	0.000342	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KDR—malignant glioma	7.32e-05	0.000342	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ASMT—malignant glioma	7.31e-05	0.000341	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—IDH1—malignant glioma	7.29e-05	0.00034	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP3—malignant glioma	7.16e-05	0.000334	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CB—malignant glioma	7.14e-05	0.000333	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN2B—malignant glioma	7.1e-05	0.000331	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SPHK1—malignant glioma	7.05e-05	0.000329	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FN1—malignant glioma	7.05e-05	0.000329	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—F2—malignant glioma	7.05e-05	0.000329	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL2—malignant glioma	7.04e-05	0.000329	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TERT—malignant glioma	7.02e-05	0.000328	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—BAD—malignant glioma	6.96e-05	0.000325	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—NCOR1—malignant glioma	6.92e-05	0.000323	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2C18—malignant glioma	6.91e-05	0.000323	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH1—malignant glioma	6.9e-05	0.000322	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTK2—malignant glioma	6.89e-05	0.000322	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—BCAN—malignant glioma	6.87e-05	0.000321	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL8—malignant glioma	6.86e-05	0.00032	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PDGFB—malignant glioma	6.85e-05	0.00032	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—BCHE—malignant glioma	6.84e-05	0.00032	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGFR1—malignant glioma	6.81e-05	0.000318	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HES1—malignant glioma	6.77e-05	0.000316	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC5A5—malignant glioma	6.76e-05	0.000316	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CD80—malignant glioma	6.76e-05	0.000316	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CG—malignant glioma	6.74e-05	0.000315	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APC—malignant glioma	6.74e-05	0.000315	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NCOR1—malignant glioma	6.73e-05	0.000314	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HIF1A—malignant glioma	6.71e-05	0.000314	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGF—malignant glioma	6.67e-05	0.000311	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—RAF1—malignant glioma	6.64e-05	0.00031	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTPN11—malignant glioma	6.63e-05	0.000309	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL2—malignant glioma	6.56e-05	0.000306	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CAV1—malignant glioma	6.49e-05	0.000303	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CB—malignant glioma	6.48e-05	0.000303	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PDGFRA—malignant glioma	6.45e-05	0.000301	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KDR—malignant glioma	6.42e-05	0.0003	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—BRAF—malignant glioma	6.34e-05	0.000296	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SPP1—malignant glioma	6.26e-05	0.000292	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—malignant glioma	6.23e-05	0.000291	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—F2—malignant glioma	6.18e-05	0.000289	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FN1—malignant glioma	6.18e-05	0.000289	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT2—malignant glioma	6.17e-05	0.000288	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—malignant glioma	6.14e-05	0.000287	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BAD—malignant glioma	6.11e-05	0.000285	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH1—malignant glioma	6.05e-05	0.000282	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2—malignant glioma	5.95e-05	0.000278	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TERT—malignant glioma	5.93e-05	0.000277	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CD—malignant glioma	5.93e-05	0.000277	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CD80—malignant glioma	5.92e-05	0.000277	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APC—malignant glioma	5.91e-05	0.000276	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CG—malignant glioma	5.91e-05	0.000276	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CA—malignant glioma	5.87e-05	0.000274	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGF—malignant glioma	5.85e-05	0.000273	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTPN11—malignant glioma	5.81e-05	0.000271	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—KRAS—malignant glioma	5.8e-05	0.000271	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PDGFB—malignant glioma	5.79e-05	0.00027	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGFR1—malignant glioma	5.76e-05	0.000269	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGF2—malignant glioma	5.68e-05	0.000265	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HIF1A—malignant glioma	5.67e-05	0.000265	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CAV1—malignant glioma	5.64e-05	0.000264	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTT1—malignant glioma	5.59e-05	0.000261	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BRAF—malignant glioma	5.56e-05	0.00026	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—IDH2—malignant glioma	5.54e-05	0.000259	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CAV1—malignant glioma	5.49e-05	0.000256	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTP1—malignant glioma	5.45e-05	0.000254	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KDR—malignant glioma	5.43e-05	0.000253	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT2—malignant glioma	5.41e-05	0.000253	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—malignant glioma	5.39e-05	0.000252	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CA—malignant glioma	5.33e-05	0.000249	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MDM2—malignant glioma	5.31e-05	0.000248	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CAT—malignant glioma	5.3e-05	0.000248	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RAF1—malignant glioma	5.29e-05	0.000247	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ERBB2—malignant glioma	5.24e-05	0.000245	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS1—malignant glioma	5.23e-05	0.000245	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—F2—malignant glioma	5.22e-05	0.000244	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FN1—malignant glioma	5.22e-05	0.000244	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.21e-05	0.000243	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CD—malignant glioma	5.2e-05	0.000243	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CB—malignant glioma	5.17e-05	0.000241	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BAD—malignant glioma	5.16e-05	0.000241	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CA—malignant glioma	5.15e-05	0.000241	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CG—malignant glioma	5.14e-05	0.00024	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	5.11e-05	0.000239	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—KRAS—malignant glioma	5.09e-05	0.000238	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CD80—malignant glioma	5.01e-05	0.000234	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—NCOR1—malignant glioma	5e-05	0.000234	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APC—malignant glioma	5e-05	0.000233	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	5e-05	0.000233	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGF2—malignant glioma	4.98e-05	0.000232	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—malignant glioma	4.97e-05	0.000232	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—malignant glioma	4.96e-05	0.000232	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGF—malignant glioma	4.94e-05	0.000231	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTPN11—malignant glioma	4.91e-05	0.000229	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—BCHE—malignant glioma	4.87e-05	0.000227	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC5A5—malignant glioma	4.81e-05	0.000225	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—malignant glioma	4.8e-05	0.000224	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—IDH1—malignant glioma	4.76e-05	0.000223	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—malignant glioma	4.75e-05	0.000222	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—malignant glioma	4.75e-05	0.000222	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BRAF—malignant glioma	4.7e-05	0.000219	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	4.68e-05	0.000218	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MDM2—malignant glioma	4.66e-05	0.000218	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RAF1—malignant glioma	4.64e-05	0.000217	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SPHK1—malignant glioma	4.61e-05	0.000215	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ERBB2—malignant glioma	4.59e-05	0.000214	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT2—malignant glioma	4.57e-05	0.000214	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—malignant glioma	4.55e-05	0.000213	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	4.53e-05	0.000212	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CD—malignant glioma	4.52e-05	0.000211	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.52e-05	0.000211	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—malignant glioma	4.49e-05	0.00021	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTEN—malignant glioma	4.47e-05	0.000209	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	4.39e-05	0.000205	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—malignant glioma	4.36e-05	0.000203	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—malignant glioma	4.35e-05	0.000203	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	4.35e-05	0.000203	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—KRAS—malignant glioma	4.3e-05	0.000201	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGF2—malignant glioma	4.21e-05	0.000196	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	4.21e-05	0.000196	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—malignant glioma	4.17e-05	0.000195	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—malignant glioma	4.16e-05	0.000194	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CAV1—malignant glioma	4.08e-05	0.000191	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—malignant glioma	4.03e-05	0.000188	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—malignant glioma	3.99e-05	0.000187	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	3.95e-05	0.000185	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CB—malignant glioma	3.94e-05	0.000184	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—malignant glioma	3.94e-05	0.000184	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MDM2—malignant glioma	3.94e-05	0.000184	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RAF1—malignant glioma	3.92e-05	0.000183	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTEN—malignant glioma	3.92e-05	0.000183	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—malignant glioma	3.9e-05	0.000182	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ERBB2—malignant glioma	3.88e-05	0.000181	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTP1—malignant glioma	3.87e-05	0.000181	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	3.83e-05	0.000179	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—malignant glioma	3.82e-05	0.000178	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CAT—malignant glioma	3.77e-05	0.000176	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CG—malignant glioma	3.72e-05	0.000174	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—malignant glioma	3.71e-05	0.000173	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—malignant glioma	3.68e-05	0.000172	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTT1—malignant glioma	3.65e-05	0.000171	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—malignant glioma	3.63e-05	0.00017	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—malignant glioma	3.59e-05	0.000168	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NCOR1—malignant glioma	3.56e-05	0.000166	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	3.55e-05	0.000166	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—malignant glioma	3.54e-05	0.000165	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—malignant glioma	3.52e-05	0.000165	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—malignant glioma	3.52e-05	0.000164	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—malignant glioma	3.5e-05	0.000164	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KRAS—malignant glioma	3.43e-05	0.00016	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS1—malignant glioma	3.42e-05	0.00016	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTEN—malignant glioma	3.4e-05	0.000159	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—malignant glioma	3.33e-05	0.000155	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTEN—malignant glioma	3.31e-05	0.000155	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.27e-05	0.000153	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—malignant glioma	3.25e-05	0.000152	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—malignant glioma	3.23e-05	0.000151	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—malignant glioma	3.18e-05	0.000149	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—BCHE—malignant glioma	3.18e-05	0.000149	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CA—malignant glioma	3.15e-05	0.000147	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.14e-05	0.000147	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—malignant glioma	3.05e-05	0.000142	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KRAS—malignant glioma	3.01e-05	0.00014	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—malignant glioma	2.99e-05	0.00014	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—malignant glioma	2.96e-05	0.000138	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CAV1—malignant glioma	2.9e-05	0.000135	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.85e-05	0.000133	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—malignant glioma	2.82e-05	0.000132	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	2.76e-05	0.000129	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—malignant glioma	2.75e-05	0.000128	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—malignant glioma	2.69e-05	0.000126	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—malignant glioma	2.67e-05	0.000125	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.64e-05	0.000123	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—malignant glioma	2.57e-05	0.00012	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—malignant glioma	2.55e-05	0.000119	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KRAS—malignant glioma	2.54e-05	0.000119	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTP1—malignant glioma	2.53e-05	0.000118	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CAT—malignant glioma	2.46e-05	0.000115	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTEN—malignant glioma	2.46e-05	0.000115	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CA—malignant glioma	2.4e-05	0.000112	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	2.33e-05	0.000109	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOR1—malignant glioma	2.33e-05	0.000109	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.32e-05	0.000108	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—malignant glioma	2.26e-05	0.000105	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—malignant glioma	2.26e-05	0.000105	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.02e-05	9.46e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—malignant glioma	2.01e-05	9.37e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—malignant glioma	1.96e-05	9.16e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—malignant glioma	1.91e-05	8.91e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CAV1—malignant glioma	1.9e-05	8.86e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTEN—malignant glioma	1.75e-05	8.17e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.74e-05	8.11e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.73e-05	8.07e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—malignant glioma	1.67e-05	7.79e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.52e-05	7.09e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—malignant glioma	1.42e-05	6.62e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.32e-05	6.18e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—malignant glioma	1.31e-05	6.13e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.23e-05	5.76e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTEN—malignant glioma	1.14e-05	5.34e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—malignant glioma	1.01e-05	4.71e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CA—malignant glioma	8.07e-06	3.77e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—malignant glioma	6.59e-06	3.08e-05	CbGpPWpGaD
